Final 5-Year Follow-Up Results Evaluating Neoadjuvant Talimogene Laherparepvec Plus Surgery in Advanced Melanoma
Reinhard Dummer, David Gyorki, John Hyngstrom, Menɡ Ninɡ, Tatiana Lawrence, Merrick I. Ross
Abstract
This randomized clinical trial presents the final 5-year follow-up results of neoadjuvant talimogene laherparepvec (T-VEC) plus surgery in patients with advanced melanoma.
Topics & Concepts
MedicineNeoadjuvant therapyMelanomaOncologySurgeryGeneral surgeryInternal medicineCancerCancer researchBreast cancerCAR-T cell therapy researchCutaneous Melanoma Detection and ManagementVirus-based gene therapy research